Co-Delivery of Dihydroartemisinin and Indocyanine Green by Metal-Organic Framework-Based Vehicles for Combination Treatment of Hepatic Carcinoma

Dihydroartemisinin (DHA), a widely used antimalarial agent, has clinical potential for the treatment of hepatic carcinoma. Although chemotherapy is indispensable for tumor therapy, it is generally limited by poor solubility, low efficiency, rapid clearance, and side effects. As an emerging treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yang, Wang, Bin, Chen, Wenping, Wang, Tao, Li, Min, Shen, Zucheng, Wang, Fang, Jia, Jing, Li, Fenglan, Huang, Xiangyu, Zhuang, Junyang, Li, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610498/
https://www.ncbi.nlm.nih.gov/pubmed/36297482
http://dx.doi.org/10.3390/pharmaceutics14102047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610498/
https://www.ncbi.nlm.nih.gov/pubmed/36297482
http://dx.doi.org/10.3390/pharmaceutics14102047

Ejemplares similares